Angel Medical Systems, Inc., a privately held medical device company developing implantable technologies for heart attack detection and patient alerting, announced today that its CEO, Dr. David R. Fischell was selected as the Ernst & Young Entrepreneur of the Year 2013 NJ Regional Award winner in Biotechnology and Medical Technology.
Finalists were selected by a panel of independent judges based on success in areas such as innovation and financial performance and the entrepreneurs’ personal commitment to their businesses and communities. Dr. Fischell was announced as the winner at a special gala event held Thursday, June 13 in New Brunswick, New Jersey.
Dr. Fischell holds 114 patents and is a serial entrepreneur who has founded nine biomedical device companies in the past fifteen years. David was also the primary designer of the BX Velocity and Cypher coronary stents for Cordis, a Johnson & Johnson Company.
David Fischell, CEO of Angel Medical Systems spoke with our host at the AdvaMed Conference 2011 in Washington D.C. to discuss AngelMed’s latest Medical Device.
AngelMed came to AdvaMed to talk about their implantable heart attack detection system called the AngelMed Guardian Cardiac Monitor and Alert System that “detects and warns patients of acute episodes of cardiac ischemia related to the progression of coronary artery disease and coronary occlusion caused by vulnerable plaque ruptures”. Once an individual has a heart attack, the chance of a second episode is very likely, and with AngelMed’s Cardiac Monitor, patients will know roughly 9-12 hours before their second heart attack occurs, giving them ample time to get themselves to a hospital, according to Fischell. The device has a vibrator and alert system to notify the patient that they need to call 911 and/or get to a hospital immediately.